Dr. Kauff, who joined the institute Aug. 14, previously served as director of clinical cancer genetics at the Duke Cancer Institute, part of Durham, N.C.-based Duke University Health System. He was director of the ovarian cancer screening and prevention program at New York City-based Memorial Sloan-Kettering Cancer Center.
Dr. Kauff is a fellow of the American College of Obstetrics and Gynecology and a member of the American Society of Clinical Oncology and the American Association for Cancer Research.
In his new role, Dr. Kauff will oversee the development and incorporation of cancer genetics, which includes genetic counseling for those with a predisposition to the disease, to improve cancer care at the health system.
More articles on executive moves:
4 recent hospital, health system CEO moves
CFO of Children’s Health in Dallas steps down; 2nd finance leader to leave in a month
Rush President Michael Dandorph to resign
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
